Analysen von Sachin Jain
30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. | |
21.01.20 | Roche buy | Merrill Lynch & Co., Inc. | |
13.09.19 | Bayer buy | Merrill Lynch & Co., Inc. | |
13.09.19 | Roche buy | Merrill Lynch & Co., Inc. | |
13.09.19 | Sanofi buy | Merrill Lynch & Co., Inc. | |
13.09.19 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
14.12.18 | Sanofi buy | Merrill Lynch & Co., Inc. | |
14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
Werbung
|
|||
14.12.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
14.12.18 | Bayer buy | Merrill Lynch & Co., Inc. | |
16.11.18 | Bayer buy | Merrill Lynch & Co., Inc. | |
06.12.17 | Roche buy | Merrill Lynch & Co., Inc. | |
06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
06.09.17 | Merck buy | Merrill Lynch & Co., Inc. | |
12.06.17 | Bayer buy | Merrill Lynch & Co., Inc. | |
30.11.16 | Merck buy | Merrill Lynch & Co., Inc. | |
08.09.16 | Merck buy | Merrill Lynch & Co., Inc. | |
22.04.16 | Merck buy | Merrill Lynch & Co., Inc. | |
07.09.15 | Bayer buy | Merrill Lynch & Co., Inc. | |
29.04.15 | Roche buy | Merrill Lynch & Co., Inc. | |
29.04.15 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
09.12.14 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
03.04.14 | Bayer buy | Merrill Lynch & Co., Inc. | |
16.11.10 | Bayer buy | Banc of America Securities-Merrill Lynch | |
19.10.10 | Bayer buy | Banc of America Securities-Merrill Lynch | |
21.09.10 | Bayer buy | Banc of America Securities-Merrill Lynch | |
02.07.10 | AstraZeneca kaufen | Banc of America Securities-Merrill Lynch |